Published in ACS Nano on February 24, 2009
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol (2009) 2.97
Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev (2010) 2.37
Intravital microscopy: a novel tool to study cell biology in living animals. Histochem Cell Biol (2010) 1.51
Functionalized carbon nanotubes for potential medicinal applications. Drug Discov Today (2010) 1.39
Imaging cell biology in live animals: ready for prime time. J Cell Biol (2013) 1.35
Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv (2010) 1.32
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nat Rev Clin Oncol (2010) 1.30
Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay. ACS Nano (2010) 1.17
Intravital microscopy as a tool to study drug delivery in preclinical studies. Adv Drug Deliv Rev (2010) 1.17
Hybrid nanoparticles for detection and treatment of cancer. Adv Mater (2012) 1.16
Monofunctional and higher-valent platinum anticancer agents. Inorg Chem (2013) 1.13
Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano (2009) 1.12
Multifunctional plasmonic shell-magnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells. ACS Nano (2012) 1.11
Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone. Biomaterials (2011) 1.11
Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev (2013) 1.11
Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol (2010) 1.11
Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. Angew Chem Int Ed Engl (2010) 1.09
Effective drug delivery, in vitro and in vivo, by carbon-based nanovectors noncovalently loaded with unmodified Paclitaxel. ACS Nano (2010) 1.08
Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomedicine (2011) 1.06
The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett (2011) 1.06
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine (Lond) (2010) 1.04
Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit Rev Biomed Eng (2012) 1.00
Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin. Int J Nanomedicine (2011) 0.98
Safe clinical use of carbon nanotubes as innovative biomaterials. Chem Rev (2014) 0.98
Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev (2012) 0.97
Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett (2014) 0.97
Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor. Chembiochem (2011) 0.97
Gold nano-popcorn attached SWCNT hybrid nanomaterial for targeted diagnosis and photothermal therapy of human breast cancer cells. ACS Appl Mater Interfaces (2011) 0.97
Nanotechnology-based approaches in anticancer research. Int J Nanomedicine (2012) 0.93
Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer. Biomaterials (2014) 0.92
Targeted drug delivery in pancreatic cancer. Biochim Biophys Acta (2009) 0.92
Nano delivers big: designing molecular missiles for cancer therapeutics. Pharmaceutics (2011) 0.91
Carbon nanotubes in cancer therapy and drug delivery. J Drug Deliv (2011) 0.91
Aqueous cationic, anionic and non-ionic multi-walled carbon nanotubes, functionalised with minimal framework damage, for biomedical application. Biomaterials (2014) 0.90
Peptide-mediated cancer targeting of nanoconjugates. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.89
Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles. ACS Chem Biol (2013) 0.87
Exposure to carbon nanotubes leads to changes in the cellular biomechanics. Adv Healthc Mater (2013) 0.87
Biosafety of non-surface modified carbon nanocapsules as a potential alternative to carbon nanotubes for drug delivery purposes. PLoS One (2012) 0.86
Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells. Int J Nanomedicine (2011) 0.85
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. Bioimpacts (2014) 0.85
Combining portable Raman probes with nanotubes for theranostic applications. Theranostics (2011) 0.85
Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube. Int J Nanomedicine (2011) 0.85
Effect of Competitive Surface Functionalization on Dual-Modality Fluorescence and Magnetic Resonance Imaging of Single-Walled Carbon Nanotubes. J Phys Chem C Nanomater Interfaces (2012) 0.84
Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance. ACS Nano (2014) 0.84
Imaging the distribution of individual platinum-based anticancer drug molecules attached to single-wall carbon nanotubes. Nanomedicine (Lond) (2009) 0.83
CNT Nanobombs for Specific Eradication of Cancer Cells: A New Concept in Cancer Theranostics. Bioimpacts (2011) 0.83
Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes. Int J Nanomedicine (2011) 0.83
Evaluation of poly(3,4-ethylenedioxythiophene)/carbon nanotube neural electrode coatings for stimulation in the dorsal root ganglion. J Neural Eng (2014) 0.83
Nanomaterials and autophagy: new insights in cancer treatment. Cancers (Basel) (2013) 0.83
Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery. ACS Nano (2011) 0.83
Aqueous dispersions of oligomer-grafted carbon nanomaterials with controlled surface charge and minimal framework damage. Faraday Discuss (2014) 0.82
Stem cell tracking with optically active nanoparticles. Am J Nucl Med Mol Imaging (2013) 0.82
Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs. J Mol Model (2012) 0.82
Preparation of magnetic carbon nanotubes (Mag-CNTs) for biomedical and biotechnological applications. Int J Mol Sci (2013) 0.81
Unveiling Stability Criteria of DNA-Carbon Nanotubes Constructs by Scanning Tunneling Microscopy and Computational Modeling. J Drug Deliv (2011) 0.81
Photoacoustic "nanobombs" fight against undesirable vesicular compartmentalization of anticancer drugs. Sci Rep (2015) 0.81
Imaging the dynamics of endocytosis in live mammalian tissues. Cold Spring Harb Perspect Biol (2014) 0.81
Biological interactions of carbon-based nanomaterials: From coronation to degradation. Nanomedicine (2015) 0.81
Nuclear mapping of nanodrug delivery systems in dynamic cellular environments. ACS Nano (2012) 0.81
Delivery of small interfering RNAs in human cervical cancer cells by polyethylenimine-functionalized carbon nanotubes. Nanoscale Res Lett (2013) 0.81
Biocompatible carbon nanotube-chitosan scaffold matching the electrical conductivity of the heart. ACS Nano (2014) 0.80
Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles. J Biol Chem (2013) 0.80
Nanoparticle-based targeted therapeutics in head-and-neck cancer. Int J Med Sci (2015) 0.79
Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin Drug Deliv (2015) 0.79
Multifunctional Polymer-Coated Carbon Nanotubes for Safe Drug Delivery. Part Part Syst Charact (2013) 0.78
Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems. Sci Technol Adv Mater (2013) 0.78
Nanotechnology in dentistry: prevention, diagnosis, and therapy. Int J Nanomedicine (2015) 0.78
Carbon nanotube biosensors. Front Chem (2015) 0.77
Biosensing with Förster Resonance Energy Transfer Coupling between Fluorophores and Nanocarbon Allotropes. Sensors (Basel) (2015) 0.77
High resolution and dynamic imaging of biopersistence and bioreactivity of extra and intracellular MWNTs exposed to microglial cells. Biomaterials (2015) 0.76
Fluorescent graphene quantum dots as traceable, pH-sensitive drug delivery systems. Int J Nanomedicine (2015) 0.76
Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent. J Inorg Biochem (2016) 0.76
Electrostatic contribution from solvent in modulating single-walled carbon nanotube association. J Chem Phys (2014) 0.76
Multi-photon imaging of tumor cell invasion in an orthotopic mouse model of oral squamous cell carcinoma. J Vis Exp (2011) 0.76
Silver nano particles prevent platelet adhesion on immobilized fibrinogen. Indian J Clin Biochem (2011) 0.76
Biosafe nanoscale pharmaceutical adjuvant materials. J Biomed Nanotechnol (2014) 0.76
Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules. Mem Inst Oswaldo Cruz (2016) 0.76
Interaction Potency of Single-Walled Carbon Nanotubes with DNAs: A Novel Assay for Assessment of Hazard Risk. PLoS One (2016) 0.75
Octa-ammonium POSS-conjugated single-walled carbon nanotubes as vehicles for targeted delivery of paclitaxel. Nano Rev (2015) 0.75
Radiolabeling, whole-body single photon emission computed tomography/computed tomography imaging, and pharmacokinetics of carbon nanohorns in mice. Int J Nanomedicine (2016) 0.75
Functionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers. Nanoscale Res Lett (2016) 0.75
Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugates. J Biomech Eng (2014) 0.75
Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes. Beilstein J Nanotechnol (2015) 0.75
Nanoparticles: Dissected with electrons. Nat Nanotechnol (2010) 0.75
Carbon nanotubes as cancer therapeutic carriers and mediators. Int J Nanomedicine (2016) 0.75
Fabrication of enzyme-based coatings on intact multi-walled carbon nanotubes as highly effective electrodes in biofuel cells. Sci Rep (2017) 0.75
PEGylated single-walled carbon nanotubes as nanocarriers for cyclosporin A delivery. AAPS PharmSciTech (2013) 0.75
Nanotechnology and drug delivery: an update in oncology. Pharmaceutics (2011) 0.75
Selective nuclear localization of siRNA by metallic versus semiconducting single wall carbon nanotubes in keratinocytes. Future Sci OA (2015) 0.75
Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing. Theranostics (2016) 0.75
Substituent Effects in π-Stacking of Histidine on Functionalized-SWNT and Graphene. Comput Theor Chem (2015) 0.75
Novel therapeutic modalities and drug delivery in pancreatic cancer - an ongoing search for improved efficacy. Drugs Context (2012) 0.75
Dispersion of single-wall carbon nanotubes with supramolecular Congo red - properties of the complexes and mechanism of the interaction. Beilstein J Nanotechnol (2017) 0.75
Nanovectorization of DNA Through Cells Using Protamine Complexation. J Membr Biol (2016) 0.75
Interaction of liposome-encapsulated cisplatin with biomolecules. J Biol Inorg Chem (2012) 0.75
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine (2017) 0.75
Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells. Bioconjug Chem (2017) 0.75
The effects of non-invasive radiofrequency electric field hyperthermia on biotransport and biodistribution of fluorescent [60]fullerene derivative in a murine orthotopic model of breast adenocarcinoma. J Control Release (2017) 0.75
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer (2007) 12.38
Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev (2001) 10.02
Drug delivery systems: entering the mainstream. Science (2004) 9.27
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol (2006) 6.93
Head and neck cancer. Lancet (2008) 6.33
Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci U S A (2008) 4.89
Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors. Proc Natl Acad Sci U S A (2003) 4.57
A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol (2008) 4.43
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A (2006) 3.86
Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol (2006) 3.67
Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J Am Chem Soc (2004) 3.48
Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res (2008) 3.47
Carbon nanotubes: synthesis, integration, and properties. Acc Chem Res (2002) 3.32
Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl (2006) 3.17
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol (1999) 3.15
Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) (2004) 3.10
Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J Nucl Med (2007) 3.08
Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc (2005) 2.89
Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. J Am Chem Soc (2007) 2.82
Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett (2005) 2.76
Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb) (2003) 2.73
siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl (2007) 2.61
Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol (2007) 2.57
Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. Nano Lett (2008) 2.51
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc (2008) 2.40
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther (2006) 2.38
Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett (2006) 2.24
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res (2005) 2.07
Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc (2005) 1.97
The long and short of carbon nanotube toxicity. Nat Biotechnol (2008) 1.91
Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem (2005) 1.77
Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A (2006) 1.76
Direct imaging of single-walled carbon nanotubes in cells. Nat Nanotechnol (2007) 1.73
Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol (2006) 1.68
Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Ed Engl (2005) 1.61
Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl (2005) 1.55
Carbon nanohorns as anticancer drug carriers. Mol Pharm (2005) 1.43
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer (2003) 1.32
Advancing the field of drug delivery: taking aim at cancer. Cancer Cell (2003) 1.28
Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug Chem (2005) 1.21
Carbon nanotube delivery of the GFP gene into mammalian cells. Chembiochem (2006) 1.20
Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents. Cancer Res (2005) 1.19
Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma. Cancer Sci (2006) 1.18
Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin Drug Deliv (2008) 1.09
Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials (2006) 1.08
Retracted Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells. Gene Ther (2006) 1.03
Lung and systemic responses to carbon nanotubes (CNT) in mice. Toxicol Sci (2007) 0.95
Drug delivery: keeping tabs on nanocarriers. Nat Nanotechnol (2007) 0.92
Cervical cancer treatment with a locally insertable controlled release delivery system. J Control Release (2006) 0.86
Cisplatin-albumin complex for treatment of cancer of the head and neck. J Laryngol Otol (1992) 0.85
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A (2002) 9.55
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
G-protein-coupled receptors and cancer. Nat Rev Cancer (2007) 6.80
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science (2005) 5.68
Augmented Wnt signaling in a mammalian model of accelerated aging. Science (2007) 5.62
VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol (2006) 5.00
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84
G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med (2007) 4.26
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell (2002) 3.50
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell (2003) 3.42
The pentacovalent phosphorus intermediate of a phosphoryl transfer reaction. Science (2003) 3.41
Protein oxidation implicated as the primary determinant of bacterial radioresistance. PLoS Biol (2007) 3.22
Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol Biol Cell (2004) 2.99
Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev Res (Phila) (2009) 2.91
Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell (2010) 2.86
Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol Biol Cell (2003) 2.79
mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell (2009) 2.74
Regulation of cell-cell junctions by the cytoskeleton. Curr Opin Cell Biol (2006) 2.53
Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells (2005) 2.52
Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry (2002) 2.37
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res (2007) 2.21
Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol (2008) 2.21
Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers. J Am Chem Soc (2006) 2.19
A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther (2004) 2.16
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell (2008) 2.13
An essential role for Rac1 in endothelial cell function and vascular development. FASEB J (2008) 2.09
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res (2005) 2.07
Organization of the core structure of the postsynaptic density. Proc Natl Acad Sci U S A (2008) 2.06
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer (2013) 2.05
Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res (2004) 2.05
Binding-induced folding of a natively unstructured transcription factor. PLoS Comput Biol (2008) 2.04
CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest (2013) 2.00
mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell (2012) 1.99
CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem (2008) 1.93
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev (2005) 1.92
Carbon Nanotubes for Electronic and Electrochemical Detection of Biomolecules. Adv Mater (2007) 1.88
Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep (2011) 1.86
Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85
The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell (2004) 1.85
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res (2004) 1.83
Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res (2008) 1.83
Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis. Traffic (2009) 1.78
Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol (2010) 1.77
Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A (2006) 1.76
Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat Med (2012) 1.74
Role for the actomyosin complex in regulated exocytosis revealed by intravital microscopy. Proc Natl Acad Sci U S A (2011) 1.74
Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst (2010) 1.73
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol (2002) 1.69
Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem (2002) 1.69
A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells. Blood (2014) 1.68
Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification. ACS Nano (2009) 1.68
P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. J Biol Chem (2007) 1.67
Mass of the postsynaptic density and enumeration of three key molecules. Proc Natl Acad Sci U S A (2005) 1.67
mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family. Genes Dev (2002) 1.63
The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell (2006) 1.63
Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src. J Biol Chem (2003) 1.60
An invasive podosome-like structure promotes fusion pore formation during myoblast fusion. J Cell Biol (2010) 1.59
The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J Biol Chem (2006) 1.58
The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc Natl Acad Sci U S A (2002) 1.58
Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res (2011) 1.54
Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation. Cell Cycle (2011) 1.54
Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. Cancer Res (2008) 1.54
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med (2008) 1.54
Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential. Oncogene (2004) 1.52
Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase. J Biol Chem (2002) 1.52
Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci U S A (2004) 1.52
Intravital microscopy: a novel tool to study cell biology in living animals. Histochem Cell Biol (2010) 1.51
MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem (2007) 1.51
Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res (2004) 1.50
Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol (2010) 1.50
Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene (2002) 1.49
Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge. J Cell Biol (2008) 1.48
Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene (2002) 1.46
A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci Signal (2011) 1.45
Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites. Anal Chem (2007) 1.43